There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To assess predictors of achievement of 80% Medication Possession Ratio (MPR) in patients
receiving manufacturer-provided self-management services for relapsing-remitting multiple
sclerosis (RRMS) patients taking glatiramer acetate (Copaxone).